Study of Motexafin Gadolinium (MGd) in Patients With Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma
Status:
Terminated
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
The primary purpose of this study is to determine if motexafin gadolinium may be an effective
treatment for patients with chronic lymphocytic leukemia (CLL) or small lymphocytic lymphoma
(SLL). Secondly, the duration of response and the time during which patients survive without
chronic lymphocytic leukemia or small lymphocytic lymphoma worsening will be evaluated.
Additionally, the patient's response to motexafin gadolinium will be compared to the response
of the patient's cells in a laboratory to motexafin gadolinium.